We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » R&D Returns Shrink to Lowest Level in Decade, Analysis Finds
R&D Returns Shrink to Lowest Level in Decade, Analysis Finds
Drug companies’ returns on R&D investments have sunk to their lowest level since 2010 and analysts at Deloitte attribute the decline mostly to the soaring costs of clinical trials.